Acelyrin Share Price Today
(NASDAQ: SLRN)

Name: Acelyrin Share Price Today (NASDAQ: SLRN) - Acelyrin Stock Price Live Quote | INDmoney
Brand: INDmoney
Rating: 4.7 (371551 reviews)

Acelyrin share price is $2.75 & ₹236.45 as on 21 Mar 2025, 09.30 hrs IST

$2.75

▲

-0.02

(-0.72%)

Market is closed - opens 7 PM, 24 Mar 2025

View live Acelyrin share price in Dollar and Rupees. Guide to invest in Acelyrin stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Acelyrin, along with analyst recommendations, forecasts, and comprehensive financials.

Acelyrin share price movements

Today's Low: $2.73
Today's High: $2.84
$2.75
0.91%
Downside
Day's Volatility :4.05%
Upside
3.17%
52 Weeks Low: $1.85
52 Weeks High: $7.86
$2.75
32.91%
Downside
52 Weeks Volatility :76.53%
Upside
65.01%

Acelyrin (SLRN) Returns

Period	Acelyrin, Inc.	Index (Russel 2000)
3 Months	-13.52%	0.0%
6 Months	-44.33%	0.0%
1 Year	-59.2%	0.0%
3 Years	-88.3%	-13.8%

Acelyrin (SLRN) Key Statistics

in dollars & INR

Previous Close	$2.77
Open	$2.74
Today's High	$2.84
Today's Low	$2.725
Market Capitalization	$279.0M
Today's Volume	$1.4M
52 Week High	$7.86
52 Week Low	$1.845
Revenue TTM	$0.0
EBITDA	$-304.4M
Earnings Per Share (EPS)	$-2.48
Profit Margin	0.0%
Quarterly Earnings Growth YOY	0.0%
Return On Equity TTM	-44.54%

How to invest in Acelyrin Stock (SLRN) from India?

It is very easy for Indian residents to invest directly in Acelyrin from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Acelyrin stock in both Indian Rupees (INR) and US Dollars (USD). Search for Acelyrin or SLRN on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Acelyrin or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Acelyrin shares which would translate to 0.313 fractional shares of Acelyrin as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Acelyrin, in just a few clicks!

Returns in Acelyrin (SLRN) for Indian investors in Rupees

The Acelyrin stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

Acelyrin investment value today

Current value as on today

₹43,995

Returns

₹56,005

(-56.01%)

Returns from Acelyrin Stock

₹59,199 (-59.2%)

Dollar Returns

₹3,194 (+3.19%)

Indian investors sentiment towards Acelyrin (SLRN)

Period: Feb 20, 2025 to Mar 22, 2025. Change in 30 Days versus previous period

Search interest for Acelyrin Stock from India on INDmoney has increased by 0% in the last 30 days, reflecting an upward trend in search activity.

Analyst Recommendation on Acelyrin

Buy

69%Buy

30%Hold

0%Sell

Based on 13 Wall street analysts offering stock ratings for Acelyrin(by analysts ranked 0 to 5 stars)

Based on 13 analyst

Current
1M Ago
3M Ago

Buy

Hold

Sell

Analyst Forecast on Acelyrin Stock (SLRN)

What analysts predicted

Upside of 190.91%

Target:

$8.00

Current:

$2.75

Insights on Acelyrin Stock (Ticker Symbol: SLRN)

Price Movement
In the last 1 month, SLRN stock has moved up by 5.8%
SLRN vs ALNY (1 yr)
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 93.4% return, outperforming this stock by 153.7%

Acelyrin Technicals Summary

Sell

Neutral

Buy

Acelyrin is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Acelyrin (SLRN) Vs Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Acelyrin, Inc.	5.77%	-44.33%	-59.2%	-88.3%	-88.3%
Regeneron Pharmaceuticals, Inc.	-5.98%	-39.7%	-31.49%	-3.13%	46.48%
Beone Medicines Ltd	-1.33%	25.17%	63.71%	24.48%	94.93%
Vertex Pharmaceuticals Incorporated	3.92%	9.39%	20.95%	99.92%	125.52%
Alnylam Pharmaceuticals, Inc.	13.07%	4.23%	86.32%	73.08%	183.51%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Acelyrin, Inc.	NA	NA	NA	-2.4	-0.45	-0.31	NA	4.57
Regeneron Pharmaceuticals, Inc.	17.27	17.27	0.98	42.64	0.16	0.07	0.01	273.57
Beone Medicines Ltd	NA	NA	NA	1.45	-0.19	-0.06	NA	31.22
Vertex Pharmaceuticals Incorporated	32.84	NA	1.43	18.06	-0.03	0.13	NA	63.87
Alnylam Pharmaceuticals, Inc.	NA	NA	-0.49	0.71	-15.01	-0.03	NA	0.52

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Acelyrin, Inc.	Buy	$279.0M	-88.3%	NA	0.0%
Regeneron Pharmaceuticals, Inc.	Buy	$72.4B	46.48%	17.27	31.07%
Beone Medicines Ltd	NA	$29.6B	94.93%	NA	-16.92%
Vertex Pharmaceuticals Incorporated	Buy	$131.0B	125.52%	32.84	-4.86%
Alnylam Pharmaceuticals, Inc.	Buy	$36.7B	183.51%	NA	-12.37%

About Acelyrin

Acelyrin, Inc., a clinical biopharma company, focuses on identifying, acquiring, and accelerating the development and commercialization of transformative medicines. The company's lead product candidate is izokibep, a small protein therapeutic designed to inhibit IL-17A with high potency, which is in Phase 3 clinical trials for use in the treatment of Hidradenitis Suppurativa, Psoriatic Arthritis, and uveitis, as well as in Phase 2 clinical trials for use in the treatment of Axial Spondyloarthritis. It is also developing lonigutamab, a humanized immunoglobulin G1 (IgG1) monoclonal antibody which is in Phase 1 clinical trials for use in the treatment of thyroid eye disease. In addition, the company's develops SLRN-517, a fully human IgG1 monoclonal antibody targeting c-KIT, which is in preclinical stage for use in the treatment of chronic urticaria. Acelyrin, Inc. was incorporated in 2020 and is headquartered in Agoura Hills, California.

Organization	Acelyrin
Employees	0
CEO	Ms. Mina Kim J.D.
Industry	Miscellaneous

Management People of Acelyrin

Name	Title
Ms. Mina Kim J.D.	CEO & Director
Mr. Tyler Marciniak	Vice President of Investor Relations, Communications & Corporate Operations
Mr. K. Amar Murugan J.D.	Chief Legal Officer
Ms. Kelly Chow	Chief People Officer
Mr. Kenneth A. Lock	Chief Commercial Officer
Ms. Patricia A. Turney	Chief Technical Operations Officer

Important FAQs about investing in SLRN Stock from India :

What is Acelyrin share price today?

Acelyrin share price today stands at $2.75, Open: $2.74 ; Previous Close: $2.77 ; High: $2.84 ; Low: $2.73 ; 52 Week High: $7.86 ; 52 Week Low: $1.85.

The stock opens at $2.74, after a previous close of $2.77. The stock reached a daily high of $2.84 and a low of $2.73, with a 52-week high of $7.86 and a 52-week low of $1.85.

Can Indians buy Acelyrin shares?

Yes, Indians can invest in the Acelyrin (SLRN) from India.

With INDmoney, you can buy Acelyrin at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Acelyrin at zero transaction cost.

How can I buy Acelyrin shares from India?

It is very easy to buy Acelyrin from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Acelyrin (SLRN) be purchased?

Yes, you can buy fractional shares of Acelyrin with INDmoney app.

What are the documents required to start investing in Acelyrin stocks?

To start investing in Acelyrin, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.